JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

Search

Edwards Lifesciences Corp

Fechado

SetorSaúde

79.94 5.8

Visão Geral

Variação de preço das ações

24h

Atual

Mín

78.92

Máximo

79.99

Indicadores-chave

By Trading Economics

Rendimento

-29M

356M

Vendas

27M

1.4B

P/E

Médio do Setor

31.636

38.156

EPS

0.64

Margem de lucro

25.228

Funcionários

15,800

EBITDA

-50M

434M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+10.25% upside

Dividendos

By Dow Jones

Próximos Ganhos

23 de out. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

150M

45B

Abertura anterior

74.14

Fecho anterior

79.94

Sentimento de Notícias

By Acuity

26%

74%

42 / 375 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Weak Bearish Evidence

Edwards Lifesciences Corp Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

25 de out. de 2024, 09:10 UTC

Ganhos

These Stocks Are Moving the Most Today: Tesla, Capri, Western Digital, Spirit Airlines, Deckers, Coursera, and More -- Barrons.com

25 de out. de 2024, 08:35 UTC

Ganhos

These Stocks Are Moving the Most Today: Tesla, Capri, Western Digital, Spirit Airlines, Deckers, Coursera, and More -- Barrons.com

3 de set. de 2024, 20:38 UTC

Aquisições, Fusões, Aquisições de Empresas

Edwards Lifesciences: After Recent Accelerated Repurchase Agreement and August Buybacks Via 10b5-1 Agreement and Open Market Repurchases, Company Has $1.4B in Remaining Authorization

3 de set. de 2024, 20:37 UTC

Aquisições, Fusões, Aquisições de Empresas

Edwards Lifesciences Completes Sale of Critical Care Group to Becton Dickinson for $4.2B

3 de set. de 2024, 20:36 UTC

Aquisições, Fusões, Aquisições de Empresas

Edwards Lifesciences Authorizes $1.5B of Additional Share Repurchases

Comparação entre Pares

Variação de preço

Edwards Lifesciences Corp Previsão

Preço-alvo

By TipRanks

10.25% parte superior

Previsão para 12 meses

Média 88.2 USD  10.25%

Máximo 101 USD

Mínimo 79 USD

Com base em 23 analistas de Wall Street que oferecem metas de preço de 12 meses para Edwards Lifesciences Corp - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

23 ratings

13

Comprar

10

Manter

0

Vender

Pontuação Técnica

By Trading Central

74.52 / 75.54Suporte e Resistência

Curto Prazo

Weak Bearish Evidence

Médio Prazo

Strong Bullish Evidence

Longo Prazo

Strong Bullish Evidence

Sentimento

By Acuity

42 / 375 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Edwards Lifesciences Corp

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.